1. BLUMBERG, H & DAYTON, H.B. (1972) Narcotic antagonist studies with EN-1639A (N-Cyclopropylmethylnoroxymorphone hydrochloride). In Fifth International Congress on Pharmacology, Volunteer Abstracts. San Francisco, July, p. 23.
2. BRUNI, J.F., VAN VUGT, D., MARSHALL, S. & MEITES, J. (1977) Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone. Life Sci. 21, 461–466.
3. BUCHSBAUM, M.S., DAVIS, G.C. & BUNNEY, W.E. JR. (1977) Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature 270, 620–622.
4. CICERO, T.J., BADGER, T.M., WILCOX, C.E., BELL, R.D. & MEYER, E.R. (1977) Morphine decreases luteinizing hormone by an action on the hypothalamic-pituitary axis. J. Pharmacol. Exp. Ther. 203, 548–555.
5. CICERO, T.J. & DORNBUSH, R. (1979) in Research Advances in Alcohol and Drug Abuse (Kalant, O., Kalant, H. and Israel, Y., eds.) Vol. 5 (in press). Plenum Press, New York.